| Financial Year |
March 31 2023 |
| Monetary Funds |
1,402,349,664.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
872,937,529.49 |
| Accounts Receivable |
4,705,583,228.57 |
| Advances to Suppliers |
99,309,336.92 |
| Other Receivables |
430,640,539.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
400,000.00 |
| Inventories |
2,653,790,636.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
34,894,568.67 |
| Other Current Assets |
117,862,423.59 |
| Total Current Assets |
11,887,294,837.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,864,660.97 |
| Long-term Equity Investment |
400,491,362.09 |
| Investment Properties |
20,527,341.17 |
| Fixed Assetes |
3,067,805,316.33 |
| Under-construction Projects |
152,027,203.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,362,487.89 |
| R&D expenses |
29,598,068.46 |
| Goodwill |
2,593,216.05 |
| Long-Term Deferred and Prepaid Expenses |
106,614,345.78 |
| Deferred Income Tax Assets |
225,321,828.00 |
| Other Non-Current Assets |
727,715,387.96 |
| Sub-Total of Non-Current Assets |
5,580,814,933.20 |
| Total Assets |
17,468,109,770.70 |
| Short-Term Loans |
904,292,329.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,589,907,040.17 |
| Accounts Payable |
4,248,765,261.47 |
| Accounts Received In Advance |
71,428.57 |
| Employee Compensation Payable |
136,393,243.30 |
| Taxes Payable |
86,970,778.39 |
| Interest Payable |
-- |
| Dividend Payable |
46,774,687.05 |
| Other payables |
890,172,855.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
430,220,524.51 |
| Other Current Liabilities |
6,179,907.49 |
| Sub-Total of Current Liabilities |
8,384,058,478.66 |
| Long-term Loans |
935,495,357.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
25,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
457,596,211.01 |
| Deferred Income Tax Liabilities |
22,547,172.96 |
| Other Non-Current Liabilities |
49,301,322.81 |
| Sub-Total of Non-Current Liabilities |
2,647,755,314.04 |
| Total Liabilities |
11,031,813,792.70 |
| Paid-In Capital(Or Share Stock) |
802,798,152.00 |
| Capital Surplus |
3,173,160,052.58 |
| Surplus Reserve |
241,216,072.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,557,452,950.09 |
| Minority Stockholder's Interest |
785,424,110.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,650,871,867.03 |
| Owner's Equity（Stockholder's Equity） |
6,436,295,978.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,468,109,770.70 |
